Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Particle Therapy
... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Patient Blood Management
... at a CAGR of 6.5% over the analysis period 2024-2030. Patient Blood Management Instruments, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$10.1 Billion by the ... Read More
-
Preimplantation Genetic Testing
... at a CAGR of 10.1% over the analysis period 2024-2030. Preimplantation Genetic Testing Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$794.1 Million ... Read More
-
Rapid Microbiology Testing
... at a CAGR of 7.5% over the analysis period 2024-2030. Rapid Microbiology Testing Instruments, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$4.9 Billion by the ... Read More
-
Specialty Picture Archiving and Communication Systems (PACS)
... expected to reach US$4.9 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Specialty PACS Software, one of the segments analyzed in the report, is expected to record a 5.9% ... Read More
-
Structural Heart Imaging (SHI)
... 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. Echocardiogram Modality, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$27.5 Billion by the ... Read More
-
Wide Field Imaging Devices
... 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Table Top Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$680.4 Million by ... Read More
-
Medical X-Ray
... CAGR of 5.1% over the analysis period 2024-2030. Digital Technology, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$13.5 Billion by the end of the analysis ... Read More
-
Prenatal Diagnostics
... CAGR of 12.8% over the analysis period 2024-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.6 Billion by the end of the analysis ... Read More
-
Radiation Detection, Monitoring and Safety Products
... reach US$3.0 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Radiation Detection & Monitoring Products, one of the segments analyzed in the report, is expected to record a 4.6% ... Read More
-
Hematology Instruments and Reagents
... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Hematology Analyzers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the ... Read More
-
High Content Screening (HCS)
... 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. HCS Instruments, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$1.0 Billion by the ... Read More
-
Advanced (3D/4D) Visualization Systems
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. MRI Modality, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$1.7 Billion by the ... Read More
-
Circulating Tumor Cell (CTC) Diagnostics
... Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Detection & Enrichment Technology, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach ... Read More
-
Point of Care Data Management Software
... reach US$2.0 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Medical Imaging Workstations
... at a CAGR of 6.8% over the analysis period 2024-2030. Computed Tomography, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$3.8 Billion by the end of ... Read More
-
Rabies Diagnostics
... CAGR of 5.4% over the analysis period 2024-2030. Fluorescent Antibody Tests (FAT) Method, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$910.1 Million by the end ... Read More
-
Therapeutic Drug Monitoring
... at a CAGR of 8.4% over the analysis period 2024-2030. Therapeutic Drug Monitoring Consumables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.5 Billion by the ... Read More
-
Imaging Agents
... CAGR of 4.5% over the analysis period 2024-2030. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More
-
Mammography Equipment
... CAGR of 6.8% over the analysis period 2024-2030. 2-D Digital Mammography Systems, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.1 Billion by the end of ... Read More
-
Cholesterol Testing
... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the ... Read More
-
Flow Cytometry Products and Services
... Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Cell-Based Flow Cytometry Technology, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach ... Read More
-
Spectroscopy Equipment and Accessories
... 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Molecular Spectroscopy, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$7.6 Billion by the ... Read More
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029
... to a number of important factors. The growing requirement for point-of-care diagnostics is one of an important factor. The necessity for fast and accurate diagnosis has risen due to the increase in chronic diseases like ... Read More
-
Medical Microbiology Testing Technologies
... 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Respiratory Diseases Indication, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.4 Billion by ... Read More
Research Assistance
